Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results |
| |
| Institution: | 1. Department of Anesthesia, Emergency and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;2. Institute of Anesthesiology and Intensive Care Medicine, Università Cattolica del Sacro Cuore, Rome, Italy;3. Department of Women''s and Children''s health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;4. Institute of Obstetrical and Gynecological clinic, Università Cattolica del Sacro Cuore, Rome, Italy |
| |
| Abstract: | Ovarian cancer (OC) is the sixth most common neoplasm in women. Hyperthermic intraperitoneal chemotherapy (HIPEC), a strategy combining maximal cytoreductive surgery with maximal regional chemotherapy, has been proposed to treat OC. At present, less randomized trials has determined HIPEC real impact on patients with OC. In this brief report, we reported results of selected studies of treatment with HIPEC for patients with OC. Future prospects are conclusively discussed. |
| |
| Keywords: | Ovarian cancer HIPEC |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
